Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus
Phase 4
Completed
- Conditions
- Fatty LiverHepatitis C
- Interventions
- Behavioral: Xenicare ProgramDrug: Xenical, Pegasys, Copegus
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- Brooke Army Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00207311
- Locations
- 🇺🇸
Brooke Army Medical Center, Ft. Sam Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath